INVO Bioscience (INVO) Reports Q1 Loss of $0.20

INVO Bioscience (NASDAQ: INVO) reported Q1 EPS of ($0.20). Revenue for the quarter came in at $340 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on INVO Bioscience (INVO) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• FOMC minutes from July 28-29th meeting
• Estee Lauder shares jump as fiscal 2027 profit forecast tops estimates